steadymed.com

Steadymed Therapeutics

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

http://www.steadymed.com/

OVERVIEW OF steadymed.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

13

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR STEADYMED.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 18 reviews

5 star

9

4 star

4

3 star

4

2 star

0

1 star

1

Hey there! Start your review of steadymed.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.6 seconds

FAVICON PREVIEW

16x16

CONTACTS AT STEADYMED.COM

SteadyMed

YAldar Aldar

Haba●●●●l 27

Tel●●●viv , 69710

IL

972-5●●●●●11222

al●●●●@017.net.il

View this contact

Y. Aldar

Chen Almog

5 Ope●●●●●er st

Re●●ot , 76701

IL

972-●●●●9556

972-●●●●9558

ch●●@steadymed.com

View this contact

NetVision LTD.

WAN Group

Omega Center Ad●●●●●●●●●●●●●●●gy Center MATAM

Ha●●fa , IL, 61620

IL

972-●●●●0514

re●●●●●●●@netvision.net.il

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 November 12
UPDATED: 2013 September 17
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

18

YEARS
6

MONTHS
18

DAYS

NAME SERVERS

1: dns.netvision.net.il
2: nypop.elron.net

REGISTRAR

DOMAIN THE NET TECHNOLOGIES LTD.

WHOIS : whois.domainthenet.com

REFERRED : http://www.domainthenet.com

CONTENT

PAGES IN
THIS WEBSITE

13

SSL

EXTERNAL LINKS

13

SITE IP

209.245.121.174

LOAD TIME

1.625 sec

SCORE

6.2

PAGE TITLE

Steadymed Therapeutics | steadymed.com Reviews

<META> DESCRIPTION

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

<META> KEYWORDS

1 skip to navigation

2 learn more

3 the patchpump

4 video

5 watch now

6 featured article

7 advanced delivery systems

8 latest news

9 see all news

10 community

CONTENT

Page content here

KEYWORDS ON PAGE

skip to navigation,learn more,the patchpump,video,watch now,featured article,advanced delivery systems,latest news,see all news,community,site 'primary' navigation,about us,strategy,leadership,board of directors,careers,community outreach,portfolio,news

SERVER

Apache/2.2.22 (Ubuntu)

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Steadymed Therapeutics | steadymed.com Reviews

https://steadymed.com

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

SUBDOMAINS

ir.steadymed.com

Steadymed Therapeutics | Investors | Investor Home

Q2 2015 SteadyMed Therapeutics Inc Earnings Conference Call. 160;at 1:30 pm PT. Q2 2015 SteadyMed Therapeutics Inc Earnings Conference Call. Thursday, August 13, 2015 . 1:30 pm PT . Click here for webcast. Click here to add this event to your calendar. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. . There are currently no items available. August 13, 2015. August 06, 2015.

INTERNAL PAGES

steadymed.com

1

Steadymed Therapeutics

http://www.steadymed.com/company/strategy.htm

At SteadyMed we are executing a highly focused strategy that is designed to create value for our shareholders in the short term by leveraging the technology and patient benefits of our PatchPump delivery system. 1) SPECIALTY PHARMACEUTICAL PRODUCT DEVELOPMENT IS OUR PRIMARY FOCUS. 2) OUR SECONDARY FOCUS IS LICENSING. A) Our primary partnering objective is to provide innovator or biosimilar companies an opportunity to differentiate, defend and grow their market positions. SteadyMed embraces an individual,...

2

Steadymed Therapeutics

http://www.steadymed.com/company/news-events

SteadyMed is about to expand the limits of parenteral therapeutics with PatchPump. To learn more about SteadyMed in the news, significant corporate milestones, our ongoing commitment to the community, or upcomming events we will be attending, please see below. Latest News currently unavailable. No events are planned at this time. At Home Patient Analgesia.

3

Steadymed Therapeutics

http://www.steadymed.com/index.php

The breakthrough in parenteral therapeutics has begun. Trevyent is an investigational drug not approved for use in any jurisdiction. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. At Home Patient Analgesia.

4

Steadymed Therapeutics

http://www.steadymed.com/portfolio/trevyent.htm

Pulmonary Arterial Hypertension (PAH) is a life threatening, progressive disease caused by narrowing or tightening (constriction) of the pulmonary arteries, which connect the right side of the heart to the lungs. There is no cure for PAH, and it worsens over time. The most common symptoms associated with the disease include breathlessness, fatigue, weakness, angina, syncope, and abdominal distension. Trevyent is a development stage product that is not currently approved for sale by the US FDA. Treprostin...

5

Steadymed Therapeutics

http://www.steadymed.com/company/leadership-bios/index.htm

JONATHAN RIGBY, MBA. DAVID W. NASSIF. Executive Vice President and CFO. PETER D. NOYMER, PH.D. EVP of Research and Development, CTO. ROBERT ZWOLINSKI, MBA. At Home Patient Analgesia.

UPGRADE TO PREMIUM TO VIEW 8 MORE

TOTAL PAGES IN THIS WEBSITE

13

LINKS TO THIS WEBSITE

radbiomed.com

Radbiomed, Technology incubator

http://www.radbiomed.com/SteadyMed

Tel: 1.510.589.3268. For more information, please visit:. Strategic Partnerships and Marketing. The market for Biologic drugs, drugs that need to be injected or infused, is continuously growing. The current global Biologic drug market is valued at $120 billion. Current injection technologies can deliver only small dosages and low viscosity drugs, thus addressing only half of the biologic drugs market potential.

kbpartners.com

Angel Investments

http://www.kbpartners.com/investments/angel-investments

Venture Funds I and II. KB Partners has raised two early stage technology oriented traditional venture capital funds, KB Partners Venture Fund I and KB Partners Venture Fund II, from a group of high net worth individuals and institutional investors. Both funds have been fully invested and principal Keith Bank is now investing personal capital in individual deals in combination with a variety of co-investors, in lieu of raising any additional institutional venture funds. Technology Products and Services.

kbpartners.com

Angel Investments

http://www.kbpartners.com/investments-home/angel-investments

Venture Funds I and II. KB Partners has raised two early stage technology oriented traditional venture capital funds, KB Partners Venture Fund I and KB Partners Venture Fund II, from a group of high net worth individuals and institutional investors. Both funds have been fully invested and principal Keith Bank is now investing personal capital in individual deals in combination with a variety of co-investors, in lieu of raising any additional institutional venture funds. Technology Products and Services.

visionpoint.co.il

לקוחות החברה

http://visionpoint.co.il/clients.asp

מר איל שימחון - מנכל Mechanical Devices. צוות חברת Vision Point ביצע עבודה מעולה לשביעות רצוננו, עמדו בלוז המתוכנן, והתוכנית העסקית סייעה לנו רבות בתכנון וביצוע המיזם. אנחנו ממליצים על צוות החברה לביצוע מיזמים שונים בעולם התעשייה, לחברות וגופים ממשלתיים. לעיון במסמך המקור לחץ כאן. Robin JR Blatt Director. Director Boston Haifa Life Sciences Initiative ( BHLSI. Adjunct Lecturer, Harvard School of Public Health. That have been part of our binational business delegations to Boston. Ralph lauren polo store.

springboard.pro

Usability | Springboard

http://www.springboard.pro/category/usability

Skip to primary content. Skip to secondary content. Why work with us? Latest news on wearable bolus (large volume) injectors. We have received a great number of enquiries for the latest information on wearable bolus (large volume) injectors, especially since our article “ The Rise of the Bolus Injector. 8221; was published. Head over to OnDrugDelivery to read the latest news on bolus injectors. Or read the whole edition devoted to large volume injectors. Hot topics in injectable drug delivery. Interestin...

UPGRADE TO PREMIUM TO VIEW 8 MORE

TOTAL LINKS TO THIS WEBSITE

13

SOCIAL ENGAGEMENT

pages/SteadyMed-Therapeutics/191641057632512

SMTherapeutics

OTHER SITES

steadymarvin.deviantart.com

steadymarvin (Martyn Davies) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Design and Interfaces / Artist. Deviant for 8 Years. This deviant's full pageview. Last Visit: 100 weeks ago. This is the place where you can personalize your profile! You can drag and drop to rearrange. Perso...

steadymarvin.livejournal.com

steadymarvin

Upgrade to paid account! Welsh cycling guitarist (now there's a trick). Editor of the Encyclopedia Spuria. My other blog is a potch. 23 February 2006 @ 11:30 pm. I manage to alleviate the 9 to 5 drudgery and break the monotonous tedium by working for half an hour. Either side of what I can only assume was a head-fit I discover the joys of Mountain Glaring. I believe that I won 3-0. Tomorrow we will have a re-match. Again I call Curly Frumphifflig to see if he could come out to play. He said he couldn...

steadymax.com

steadymax.com is coming soon

Is a totally awesome idea still being worked on.

steadymaxx.com

SteadyMaxx.com

SteadyMaxx GmbH Emsstr.23 D-46117 Oberhausen.

steadymed.co.il

Steadymed Therapeutics

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

steadymed.com

Steadymed Therapeutics

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

steadymed.net

Steadymed Therapeutics

The breakthrough in parenteral therapeutics has begun. We are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. The most size efficient and scalable delivery product for injectable drugs. SteadyMed appears in the October 2013 edition of Drug Development and Delivery Magazine. At Home Patient Analgesia.

steadymedia.com

steadymedia.com - This website is for sale! - Media Resources and Information.

The owner of steadymedia.com. Is offering it for sale for an asking price of 2900 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

steadymedia.net

Steadymedia: Website Design, Hosting, Social Marketing, Mobile Applications

Welcome to the home of Steadymedia. Our website is undergoing a few updates at the moment, Please check back soon. Date Created: Thu May 12 13:31:13 2016.

steadymenu.com

SteadyMenu - Home

steadymerch.com

test page | steady test page

Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Vc single image][/vc column inner]. Vc row inner][/vc column][/vc row]. Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Vc single image][/vc column inner]. Vc row inner][/vc column][/vc row]. Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Contact us now kkh kjhdk kjkuhdk jhgu7ty j jhg uyyg. Vc single image][/vc column inner].